Immunoassay Market Future Plans, Business Distribution, Application, Trend Outlook and Competitive Landscape
Immunoassays are analytical methods in which the quantitation of the analyte depends on the reaction of an antigen and an antibody. Immunoassays incorporate a variety of different labels for the detection of antibodies and antigens. These labels are generally chemically linked or conjugated to the desired antibody or antigen.
The increasing incidence of chronic and infectious diseases, growing research and development investment (R&D) activities, and technological advancements are the major factors boosting the growth of the market. Despite the drivers, the high cost of immunoassay procedures and the high price of immunoassay systems constrain the growth of the market.
The global Immunoassay Market has been segmented into type, application, and end user. By type, the market has been segmented into Enzyme-Linked Immunosorbent Assay (ELISA), Enzyme-Linked Immunospot Assay (ELISpot), Radioimmunoassay (RIA), Chemiluminescence (CLIA), Fluoroimmunoassay, and Others. On the basis of application, the market has been segmented into infectious diseases, cancer research, endocrinology, autoimmune diseases, and others. By end-user, the market has been segmented pharmaceutical and biotechnology companies, academic institutions and laboratories, and others
Request Free Sample Copy at:
Market Research Future (MRFR) recognizes the following companies as the key players in the global immunoassay in R&D market that includes Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Siemens Healthineers (Germany), Becton, Dickinson and Company (US), Danaher Corporation (US), bioMérieux Inc. (France), Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Sysmex Corporation (Japan), and Abcam plc (United Kingdom).
Geographically, the Americas is expected to dominate the global immunoassay in R&D market. The market growth is attributed to the increasing number of research projects in laboratories, growing adoption of advanced technology in research, and the growing prevalence of several diseases. The European market for immunoassay in R&D is expected to be the second-largest market due to the growing adoption in diagnostic measures is expected to boost the growth of the market in this region.
Moreover, the companies operating in the market are particularly focusing on mergers and acquisition which is expected to support the market growth. Asia-Pacific is estimated to be the fastest growing market due to the developing healthcare infrastructure and increasing disposable income. In addition to this, improving healthcare infrastructure has increased the number of research activities in the region. Moreover, in the Asia-Pacific region, South Korea accounted for a market share of 10.1% in 2017. Furthermore, the market in the Middle East & Africa is expected to witness steady growth due to limited access to healthcare facilities.
Browse Detailed TOC with COVID-19 Impact Analysis at:
Key Findings of the Study:
• Global Immunoassay Market is projected to reach USD 7,716.6 million by 2023 with 18% CAGR during the review period of 2018 to 2023
• Americas accounted for the largest share in the region due to the increasing number of research projects and the growing prevalence of chronic diseases
• The pharmaceutical and biotechnology companies segment accounted for a market value of USD 1,742.6 million in 2017
This research report provides insights, on various levels of analysis such as industry analysis, market share analysis, leading market players, and their profiles. This report also helps in studying the target segments by providing views on emerging and high-growth segments and market conclusion. Together the market data comprises and discusses basic assessments on the competitive scenarios and strategies of the global immunoassay in R&D market, including the high-growth regions and their political, economic, and technological environments. Furthermore, the project report also provides views over historical market values as well as, pricing and cost analysis of the same.
Browse More Related Reports:
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immunoassay Market Future Plans, Business Distribution, Application, Trend Outlook and Competitive Landscape here
News-ID: 2786775 • Views: 399
More Releases from Market Reasearch Future
Dry Eye Syndrome Market Growth, Future Scope, Challenges, Opportunities, Trends, …
Dry Eye Syndrome Market-Overview Dry Eye Syndrome Market is expected to reach USD 5,080.0 Million by 2030 at 5.31% CAGR during the forecast period 2022-2030 The change in the urban lifestyle and strenuous nature of the working atmosphere is estimated to increase the cases of dry eyes, and this is estimated to influence the dry eye syndrome market share in the forthcoming period. Segmental Analysis The segmental appraisal of the dry eye
Hybrid vehicle market is expected to rise at a CAGR of 30.27%
Market Overview: In addition, the global hybrid vehicle market is expected to rise at a CAGR of 30.27%, with a value of USD 1268.64 billion during the estimated the forecasting year of 2022-2030. An electric automobile is propelled by electricity as opposed to its gasoline-powered counterpart. These cars don't have internal combustion engines; instead, they run on electric motors, which need a steady source of power from batteries to function. These vehicles
Vehicle Electrification Market size expected to grow to $144.65 billion by 2030, …
Market overview: The worldwide Vehicle Electrification Market was worth $70.14 billion in 2019 and is expected to grow to $144.65 billion by 2030, at an 12.52% CAGR. Vehicle electrification is the primary driving force behind the automotive industry's big shift. Factors such as increased adoption of fuel-efficient mobility solutions, effective performance requirements, and a decrease in battery price per KWH will likely boost the worldwide vehicle electrification industry. However, a decline in
3D Imaging Market Size to Reach USD 42.5%Billion, With an 21.5% CAGR by 2030
Market Overview The extensive studies done by market experts reveal that the global 3D Imaging Market Value is expected to reach USD 42.5 billion by 2028. The study period for preparing this report is 2022-2028. From USD 21.5 billion in 2021, the 3D Imaging Market is estimated to grow with a CAGR of 21.5% during the forecast period. 3D Imaging techniques are used in many industrial sectors, such as medical, industrial automation,
More Releases for Immunoassay
Insights On Immunoassay Market Outlook - Ken Research
An immunoassay is a biochemical analysis that measures the existence or concentration of a macromolecule or a small molecule in a solution through the use of an antibody or an antigen. Immunoassays in scientific research are typically used in the study of biological systems by tracing different proteins, hormones, and antibodies. In industry, they are used to identify contaminants in food and water, and to monitor specific molecules used during
Bahrain Immunoassay Analyzer Market
Transparent healthcare framework & strict procurement system enables the authorities in gaining the trust of the end-users leading to the growth of the medical devices industry in Bahrain: Ken Research Heavy Government involvement in the industry: Bahrain has been maintaining a basic framework for a transparent, rules-based government procurement system. Bahrain hospitals and clinics, as well as developing specialist treatments, are continuously growing. This has improved the installation of BGA, POC
Bahrain Immunoassay Analyzer Market: Ken Research
The report titled "Bahrain Blood Gas and POC Immunoassay AnalyzerMarket Outlook to 2026-Multiple programs to modernize the Bahraini healthcare sector in future including Health Insurance, Health centers and Primary Care Autonomy" provides a comprehensive analysis of the Diagnostic Equipments used in Hospitals and Independent Labs. Report also covers overview and genesis of the industry, product wise market size in terms of installed base; market segmentation by type of device, type
Immunoassay Market Competitive Dynamics 2027
According to the new research report published by The Insight Partners, titled "Immunoassay Market- Global Analysis and Forecast to 2027". The global immunoassay market is US$ 21,800.0 Mn in 2018 and is predicted to grow at a CAGR of 6.5% during the forecast period 2019 - 2027, to reach US$ 37,987.8 Mn by 2027. Immunoassay Market Report presents a competitive scenario of key Immunoassay Industry players with their market share, sales, revenue
Immunoassay Market: Opportunities and Challenges
The Immunoassay Market is expected to reach 27.15 billion by 2023 from USD 20.19 billion in 2018, at a CAGR of 6.1% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436 Will the development of condition-specific biomarkers and tests create opportunities for growth for players in the immunoassay market? Biomarkers have gained significant clinical value and interest in the medical industry, as they are very useful in the screening, diagnosis, and treatment of diseases.
Immunoassay Growth Insights 2019 by Major Key Drivers like biotechnology and pha …
Immunoassay Market Highlights Immunoassay is widely used in significant areas of pharmaceutical analysis which include diagnosis of diseases and in therapeutic drug monitoring. A number of factors such as the increasing prevalence of chronic conditions, growth in the biotechnology and pharmaceutical sector, increasing adoption of rental immunoassay analyzers, rising use of immunoassay in oncology, growing awareness about immunoassay, healthcare insurance coverage for various infectious diseases, unmet medical needs, improving regulatory framework, and